What are the consequences of submitting non-compliant sequence listings in a patent application?
Submitting non-compliant sequence listings in a patent application can have serious consequences. According to MPEP 2422.07:
“Applications filed on or after January 1, 2022, that are otherwise complete, but that contain defective sequence listings, will be accepted and the defective sequence listing will be treated in accordance with 37 CFR 1.52(e)(8).”
This means:
- The application may be accepted, but the defective sequence listing will need to be corrected.
- If the defect is not corrected within the time period set in the notice, the application may be held abandoned.
- For applications filed before January 1, 2022, different rules apply, potentially resulting in the application being held incomplete.
To learn more:
Topics:
MPEP 2400 - Biotechnology,
MPEP 2422.07 - Requirements For Compliance And Consequences Of Non - Compliance,
Patent Law,
Patent Procedure